|
[1] CAPOBIANCO I,ROLINGER J,NADALIN S. Resection for Klatskin tumors:Technical complexities and results[J].Transl Gastroenterol Hepatol,2018,3:69.
|
|
[2] BLECHACZ B. Cholangiocarcinoma:Current knowledge and new developments[J]. Gut Liver,2017,11(1):13-26.
|
|
[3] NAGINO M,EBATA T,YOKOYAMA Y,et al. Evolution of surgical treatment for perihilar cholangiocarcinoma:A singlecenter 34-year review of 574 consecutive resections[J]. Ann Surg,2013,258(1):129-140.
|
|
[4] KLATSKIN G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features[J]. Am J Med,1965,38:241-256.
|
|
[5] CAI XJ. Interpretation of the 8th edition of AJCC Cancer Staging Manual"hilar cholangiocarcinoma"[J]. J Clin Surg,2018,26(1):10-12.(in Chinese)蔡秀军．美国癌症联合会(AJCC)癌症分期手册第8版“肝门部胆管癌”部分更新解读[J]．临床外科杂志，2018,26(1):10-12.
|
|
[6] MB A. AJCC cancer staging manual[M]. New York:Springer,2016.
|
|
[7] Study Group of Biliary Tract Surgery in Chinese Society of Surgery of Chinese Medical Association,Hepatobiliary Surgery Professional Committee of PLA. Guidelines for diagnosis and treatment of hilar cholangiocarcinoma(2013)[J]. Chin J Surg,2013,51(10):865-871.(in Chinese)中华医学会外科学分会胆道外科学组，解放军全军肝胆外科专业委员会．肝门部胆管癌诊断和治疗指南(2013版)[J]．中华外科杂志，2013,51(10):865-871.
|
|
[8] EBATA T,KOSUGE T,HIRANO S,et al. Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas[J]. Br J Surg,2014,101(2):79-88.
|
|
[9] LI XC,JIANG WJ. Advance in diagnosis and treatment of hilar cholangiocarcinoma[J]. J Abdominal Surg,2019,32(1):7-12.(in Chinese)李相成，江王杰．肝门部胆管癌诊治进展[J]．腹部外科，2019,32(1):7-12.
|
|
[10] BISMUTH H,CORLETTE MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver[J]. Surg Gynecol Obstet,1975,140(2):170-178.
|
|
[11] GASPERSZ MP,BUETTNER S,van VUGT J,et al. Evaluation of the New American Joint Committee on cancer staging manual 8th edition for perihilar cholangiocarcinoma[J]. J Gastrointest Surg,2019.[Epub ahead of print]
|
|
[12] SUAREZ-MUNOZ MA,FERNANDEZ-AGUILAR JL,SANCHEZ-PEREZ B,et al. Risk factors and classifications of hilar cholangiocarcinoma[J]. World J Gastrointest Oncol,2013,5(7):132-138.
|
|
[13] DEOLIVEIRA ML,SCHULICK RD,NIMURA Y,et al. New staging system and a registry for perihilar cholangiocarcinoma[J]. Hepatology,2011,53(4):1363-1371.
|
|
[14] VARGHESE JC,FARRELL MA,COURTNEY G,et al. A prospective comparison of magnetic resonance cholangiopancreatography with endoscopic retrograde cholangiopancreatography in the evaluation of patients with suspected biliary tract disease[J]. Clin Radiol,1999,54(8):513-520.
|
|
[15] FARRELL RJ,AGARWAL B,BRANDWEIN SL,et al. Intraductal US is a useful adjunct to ERCP for distinguishing malignant from benign biliary strictures[J]. Gastrointest Endosc,2002,56(5):681-687.
|
|
[16] JOO I,LEE JM,YOON JH. Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma:Recent advances and challenges[J]. Radiology,2018,288(1):7-13.
|
|
[17] OLIVEIRA IS,KILCOYNE A,EVERETT JM,et al. Cholangiocarcinoma:Classification,diagnosis,staging,imaging features,and management[J]. Abdom Radiol(NY),2017,42(6):1637-1649.
|
|
[18] CHEN HW,PAN AZ,ZHEN ZJ,et al. Preoperative evaluation of resectability of Klatskin tumor with 16-MDCT angiography and cholangiography[J]. AJR Am J Roentgenol,2006,186(6):1580-1586.
|
|
[19] LEE HY,KIM SH,LEE JM,et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma:Combined CT and cholangiography with revised criteria[J]. Radiology,2006,239(1):113-121.
|
|
[20] ALOIA TA,CHARNSANGAVEJ C,FARIA S,et al. High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma[J]. Am J Surg,2007,193(6):702-706.
|
|
[21] TILLICH M,MISCHINGER HJ,PREISEGGER KH,et al. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma[J]. AJR Am J Roentgenol,1998,171(3):651-658.
|
|
[22] RAZUMILAVA N,GORES GJ. Cholangiocarcinoma[J]. Lancet,2014,383(9935):2168-2179.
|
|
[23] PARK MJ,KIM YK,LIM S,et al. Hilar cholangiocarcinoma:Value of adding DW imaging to gadoxetic acid-enhanced MR imaging with MR cholangiopancreatography for preoperative evaluation[J]. Radiology,2014,270(3):768-776.
|
|
[24] TOUMI N,ABID H,HENCHIR S,et al. Role of magnetic resonance imaging in preoperative assessement of hilar cholangiocarcinoma[J]. Presse Med,2018,47(11-12 Pt 1):950-960.
|
|
[25] SOARES KC,KAMEL I,COSGROVE DP,et al. Hilar cholangiocarcinoma:Diagnosis, treatment options, and management[J]. Hepatobiliary Surg Nutr,2014,3(1):18-34.
|
|
[26] ROMANEEHSEN B,OTTO G,LOHSE AW,et al. Diagnostic imaging of hilar cholangiocarcinoma:Preoperative evaluation of ERC,MRC and PTC in comparison with histopathology[J].Rofo,2004,176(12):1750-1758.
|
|
[27] WEBER A,von WEYHERN C,FEND F,et al. Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma[J]. World J Gastroenterol,2008,14(7):1097-1101.
|
|
[28] HIJIOKA S,HARA K,MIZUNO N,et al. A novel technique for endoscopic transpapillary"mapping biopsy specimens"of superficial intraductal spread of bile duct carcinoma(with videos)[J]. Gastrointest Endosc,2014,79(6):1020-1025.
|
|
[29] KAWASHIMA H,ITOH A,OHNO E,et al. Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma:A retrospective study of efficacy and risk factors related to complications[J]. Ann Surg,2013,257(1):121-127.
|
|
[30] SAKUMA Y,KODAMA Y,SOGABE Y,et al. Diagnostic performance of a new endoscopic scraper for malignant biliary strictures:A multicenter prospective study[J]. Gastrointest Endosc,2017,85(2):371-379.
|
|
[31] JI GW,ZHU FP,LI XC. Progress in application of three-dimensional imaging technique in complex hepatobiliary surgery[J]. Chin J Surg,2017,55(4):316-320.(in Chinese)季顾惟，朱飞鹏，李相成．三维影像学技术在复杂肝胆外科手术中的应用进展[J]．中华外科杂志，2017,55(4):316-320.
|
|
[32] WANG Y,YANG H,SHEN C,et al. Surgical procedure and long-term survival of hilar cholangiocarcinoma[J]. Int J Clin Exp Med,2015,8(1):1122-1128.
|
|
[33] LIM JH,CHOI GH,CHOI SH,et al. Liver resection for Bismuth type I and Type II hilar cholangiocarcinoma[J]. World J Surg,2013,37(4):829-837.
|
|
[34] XIONG J,NUNES QM,HUANG W,et al. Major hepatectomy in Bismuth types I and II hilar cholangiocarcinoma[J]. J Surg Res,2015,194(1):194-201.
|
|
[35] HIROSE T,IGAMI T,EBATA T,et al. Surgical and Radiological Studies on the Length of the Hepatic Ducts[J]. World J Surg,2015,39(12):2983-2989.
|
|
[36] KUANG D,WANG GP. Hilar cholangiocarcinoma:Pathology and tumor biology[J]. Front Med China,2010,4(4):371-377.
|
|
[37] JARNAGIN WR,BOWNE W,KLIMSTRA DS,et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma[J]. Ann Surg,2005,241(5):703-712; discussion 712-714.
|
|
[38] de JONG MC,MARQUES H,CLARY BM,et al. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma:A multi-institutional analysis of 305 cases[J]. Cancer,2012,118(19):4737-4747.
|
|
[39] MATSUYAMA R,MORI R,OTA Y,et al. Significance of vascular resection and reconstruction in surgery for hilar cholangiocarcinoma:With special reference to hepatic arterial resection and reconstruction[J]. Ann Surg Oncol,2016,23(Suppl4):475-484.
|
|
[40] YOUNG AL,IGAMI T,SENDA Y,et al. Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion[J]. HPB(Oxford),2011,13(7):483-493.
|
|
[41] NAGINO M,NIMURA Y,NISHIO H,et al. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma:An audit of 50 consecutive cases[J]. Ann Surg,2010,252(1):115-123.
|
|
[42] CHEN W,KE K,CHEN YL. Combined portal vein resection in the treatment of hilar cholangiocarcinoma:A systematic review and meta-analysis[J]. Eur J Surg Oncol,2014,40(5):489-495.
|
|
[43] HARTOG H,IJZERMANS JN,van GULIK TM,et al. Resection of Perihilar Cholangiocarcinoma[J]. Surg Clin North Am,2016,96(2):247-267.
|
|
[44] MAO K,LIU J,SUN J,et al. Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma[J]. J Gastroenterol Hepatol,2016,31(2):417-426.
|
|
[45] GIULIANTE F,ARDITO F,GUGLIELMI A,et al. Association of lymph node status with survival in patients after Liver resection for hilar cholangiocarcinoma in an Italian multicenter analysis[J]. JAMA Surg,2016,151(10):916-922.
|
|
[46] KAMBAKAMBA P,LINECKER M,SLANKAMENAC K,et al.Lymph node dissection in resectable perihilar cholangiocarcinoma:A systematic review[J]. Am J Surg,2015,210(4):694-701.
|
|
[47] LI XC,JI GW. Radical resection of hilar cholangiocarcinoma[J]. J Surg Concepts Pract,2017,22(3):185-190.(in Chinese)李相成，季顾惟．肝门部胆管癌的根治性切除[J]．外科理论与实践，2017,22(3):185-190.
|
|
[48] BELGHITI J,HIRAMATSU K,BENOIST S,et al. Seven hundred forty-seven hepatectomies in the 1990s:An update to evaluate the actual risk of liver resection[J]. J Am Coll Surg,2000,191(1):38-46.
|
|
[49] KAWAKAMI H,KUWATANI M,ONODERA M,et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma[J]. J Gastroenterol,2011,46(2):242-248.
|
|
[50] ZHANG XF,BEAL EW,MERATH K,et al. Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma:Percutaneous biliary drainage has no adverse effects on survival[J]. J Surg Oncol,2018,117(6):1267-1277.
|
|
[51] MAY BJ,MADOFF DC. Controversies of preoperative portal vein embolization[J]. Hepat Oncol,2016,3(2):155-166.
|
|
[52] PICHLMAYR R,WEIMANN A,TUSCH G,et al. Indications and role of liver transplantation for malignant tumors[J]. Oncologist,1997,2(3):164-170.
|
|
[53] MEYER CG,PENN I,JAMES L. Liver transplantation for cholangiocarcinoma:Results in 207 patients[J]. Transplantation,2000,69(8):1633-1637.
|
|
[54] ROBLES R,FIGUERAS J,TURRIN VS,et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma[J]. Ann Surg,2004,239(2):265-271.
|
|
[55] de VREEDE I,STEERS JL,BURCH PA,et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma[J]. Liver Transpl,2000,6(3):309-316.
|
|
[56] HEIMBACH JK,GORES GJ,HADDOCK MG,et al. Liver transplantation for unresectable perihilar cholangiocarcinoma[J]. Semin Liver Dis,2004,24(2):201-207.
|
|
[57] ROSEN CB,HEIMBACH JK,GORES GJ. Liver transplantation for cholangiocarcinoma[J]. Transpl Int,2010,23(7):692-697.
|
|
[58] GORES GJ,DARWISH MURAD S,HEIMBACH JK,et al. Liver transplantation for perihilar cholangiocarcinoma[J]. Dig Dis,2013,31(1):126-129.
|
|
[59] MACHAIRAS N,KOSTAKIS ID,TSILIMIGRAS DI,et al. Liver transplantation for hilar cholangiocarcinoma:A systematic review[J]. Transplant Rev(Orlando),2020,34(1):100516.
|
|
[60] DARWISH MURAD S,KIM WR,HARNOIS DM,et al. Efficacy of neoadjuvant chemoradiation,followed by liver transplantation,for perihilar cholangiocarcinoma at 12 US centers[J].Gastroenterology,2012,143(1):88-98. e3; quiz e14.
|
|
[61] MORIS D,KOSTAKIS ID,MACHAIRAS N,et al. Comparison between liver transplantation and resection for hilar cholangiocarcinoma:A systematic review and meta-analysis[J].PLo S One,2019,14(7):e0220527.
|
DownLoad: